Reverse transcriptase: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 6: | Line 6: | ||
*[[Transcription and RNA Processing]]<br /> | *[[Transcription and RNA Processing]]<br /> | ||
*[[HIV-1 Reverse Transcriptase in Complex with Nevirapine]]<br /> | *[[HIV-1 Reverse Transcriptase in Complex with Nevirapine]]<br /> | ||
*[[Efavirenz]]<br /> | |||
*[[Emtricitabine]]<br /> | |||
*[[Efavirenz/emtricitabine/tenofovir]]<br /> | |||
*[[Phl p 2]]<br /> | *[[Phl p 2]]<br /> | ||
*[[Tenofovir disoproxil]]<br /> | |||
*[[AZT-resistant HIV-1 reverse transcriptase]]<br /> | *[[AZT-resistant HIV-1 reverse transcriptase]]<br /> | ||
*[[Catalytic Subunit of T. Castaneum TERT Polymerase]].<br /> | *[[Catalytic Subunit of T. Castaneum TERT Polymerase]].<br /> | ||